People Welcome to Larry Senour We are excited to welcome Larry Senour to Genetic Intelligence to help lead business development. Larry has 30 years of healthcare experience in strategy, operations and transaction roles, including 23 years with Merck & Co., Inc. In his last role at Merck he was Managing Director of Healthcare Services &
Media VIDEO: Experience Genetic Intelligence Watch the Genetic Intelligence vision. Genetic Intelligence finds truly causal disease targets and designs medicines to fix them. With Genetic Intelligence, you can step into the future of drug discovery. You can take in all of the interconnected parts of your program in full clarity. You can drive better collaboration,
Bergspitze Shifting perspectives on our WGS and lower sample numbers focus Increasingly, we are seeing the genetic field slowly pivot toward the path we at GI have insisted on (and blazed) all along. Namely, 1) whole genome (WGS) instead of whole exome (WES) and 2) well characterized cohorts (which can mean smaller number of samples) instead of larger and larger studies.
Update Genetic Intelligence awarded Competitive grant from the National Science Foundation Genetic Intelligence has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $225,000 to conduct research and development (R&D) work on causal disease gene identification from Whole Genomes using Artificial Intelligence
Getting Started Welcome to the Genetic Intelligence Brief The GI Brief is designed to be concise, accessible, and bearer of answers. Let's jump in.
